Oramed Pharmaceuticals
ORMP
ORMP
24 hedge funds and large institutions have $850K invested in Oramed Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $43K
Holders
24
Holding in Top 10
–
Calls
–
Puts
$43K
Top Buyers
| 1 | +$90.6K | |
| 2 | +$73.6K | |
| 3 | +$32.6K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$10.4K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$4.56K |
Top Sellers
| 1 | -$508K | |
| 2 | -$32.6K | |
| 3 | -$19K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.94K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.56K |